SAN FRANCISCO (MarketWatch) -- Maxim Pharmaceuticals Inc. said Wednesday that its drug Ceplene was granted orphan drug designation by the European Commission for the treatment of acute myeloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results